Diabetics shouldn't forget their antioxidents: study
- NEW -
July 10, 2008 - Vitamins C and E supplements may reduce memory loss in type-2 diabetics, a population at risk of increased impaired memory, suggests a new study from Canada.

Diabetes Drug May Slow Eye Disease
- NEW -
July 1, 2008 - The medication rosiglitazone may slow the progression of eye disease in diabetes patients, according to the new research from the Jules Stein Eye Institute at the University of California, Los Angeles

Thiamine Deficiency in Diabetics Tied to Vascular Disease
August 24, 2007 - Increased clearance of thiamine in type 1 and type 2 diabetic patients leads to deficiency of the vitamin, and this is reflected in levels of a marker of endothelial dysfunction, UK researchers report in the August issue of Diabetologia.

Long-term vision for vitamin C and diabetic eye health?
June 27, 2007 - Long-term supplementation with vitamin C may one day help prevent diabetic retinopathy, the most common diabetic eye disease, if preliminary results from animals can be reproduced in humans. The new study, published in the Elsevier journal, Microvascular Research, compared the effects of vitamin C supplementation on the development of diabetes retinopathy and found significant improvements in markers of eye health.

Diabetes Drug Costs Could Soar 70 Pct by '09: Report
May 17, 2007 - A growing diabetes epidemic and more aggressive treatment with combination drug therapies could result in a rise of nearly 70 percent in drug spending on the disease through 2009, according to a report released by Medco Health Solutions Inc. Medco's 2007 Drug Trend Report found diabetes treatments trailing only cholesterol medications in total prescription drug spending growth in 2006.

Study: Pill raises risk of heart attacks
May 21, 2007 - The widely prescribed diabetes drug Avandia is linked to a greater risk of heart attack and possibly death, a new scientific analysis revealed.

Low Serum Zinc a Risk Factor for Coronary Events in Type 2 Diabetics
March 12, 2007 - In middle-aged type 2 diabetics, a low blood level of zinc is an independent risk factor for coronary heart disease (CHD) events, a study in the March 2007 issue of Diabetes Care shows.

Diabetes Drug May Up Bone Fractures
February 22, 2007 - Women taking the diabetes drugs Avandia, Avandamet, or Avandaryl may be more likely to fracture their bones than those using other diabetes drugs.

Chromium picolinate plus biotin may help diabetes control
January 10, 2007 - A daily supplement of chromium picolinate and biotin improved glucose tolerance by 15 per cent, compared to placebo, says a new study from Yale University. This pilot study demonstrates that supplementation with a combination of chromium picolinate and biotin in poorly controlled patients with diabetes receiving anti-diabetic therapy improved glucose management and several lipid measurements.

Chromium Supplement Offers Diabetes Hope – Animal Study
February 2, 2006 - Researchers have reported how chromium picolinate improves muscle sensitivity to insulin in obese, insulin-resistant rats. Through this, chromium picolinate improves the uptake of glucose inside the cells and helps in lowering the blood sugar levels. These findings could have implications for diabetic humans.